Capital Fund Management S.A. Ardelyx, Inc. Transaction History
Capital Fund Management S.A.
- $37.9 Billion
- Q4 2024
A detailed history of Capital Fund Management S.A. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 313,064 shares of ARDX stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
313,064
Previous 95,811
226.75%
Holding current value
$1.58 Million
Previous $660,000
145.15%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
233Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Janus Henderson Group PLC London, X024.4MShares$123 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$88.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$72.4 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$58.4 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$52.1 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $779M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...